Weak evidence on nalmefene creates dilemmas for clinicians and poses questions for regulators and researchers

Niamh Fitzgerald, Kathryn Angus, Andrew Elders, Marisa de Andrade, Duncan Raistrick, Nick Heather, Jim McCambridge

Research output: Contribution to journalArticlepeer-review

28 Citations (Scopus)
2 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Weak evidence on nalmefene creates dilemmas for clinicians and poses questions for regulators and researchers'. Together they form a unique fingerprint.

Medicine & Life Sciences